We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 258 results
  1. Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study

    Purpose

    To evaluate whether quantitative whole-body (WB) PSMA-PET metrics under long-term androgen deprivation therapy (ADT) and/or androgen receptor...

    Vishnu Murthy, Emmanuel Appiah-Kubi, ... Ida Sonni in European Journal of Hybrid Imaging
    Article Open access 02 October 2023
  2. Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing

    Androgen receptor (AR), is a transcription factor and a member of a hormone receptor superfamily. AR plays a vital role in the progression of...

    Kalpit Shah, Teresa Gagliano, ... Michael Dean in Oncogene
    Article Open access 20 August 2020
  3. Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer

    Prostate cancer progression is connected to the activity of conventional oncogenes and tumour suppressors and driven by circulating steroid hormones....

    Rahul Advani, Sara Luzzi, ... David J. Elliott in Oncogene
    Article Open access 26 September 2023
  4. Bicalutamide/goserelin

    Article 02 September 2023
  5. Single-cell analysis reveals androgen receptor regulates the ER-to-Golgi trafficking pathway with CREB3L2 to drive prostate cancer progression

    Androgen receptor (AR) plays a central role in driving prostate cancer (PCa) progression. How AR promotes this process is still not completely clear....

    Lingling Hu, **n Chen, ... Edwin Cheung in Oncogene
    Article 05 October 2021
  6. Multiple drugs

    Article 07 January 2023
  7. Dexamethasone

    Article 04 December 2021
  8. Multiple drugs

    Article 30 October 2021
  9. The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer

    Androgen receptor (AR) plays a vital role in prostate cancer (PCa), including castration-resistant PCa, by retaining AR signalling. Androgen...

    Liuxun Li, Jiangli Xu in Clinical and Translational Oncology
    Article Open access 06 October 2022
  10. Abiraterone/prednisone

    Article 07 December 2019
  11. Nur77 suppression facilitates androgen deprivation-induced cell invasion of prostate cancer cells mediated by TGF-β signaling

    Background

    Androgen deprivation therapy (ADT) remains a standard treatment for advanced prostate cancers. However, recent studies revealed that while...

    J. Wu, H. Sun, ... X. Sun in Clinical and Translational Oncology
    Article 28 March 2018
  12. Kombinierte Systemtherapie beim metastasierten hormonsensitiven Prostatakarzinom: Was? Wann? Bei wem?

    Novel combination therapies are currently the standard systemic treatment for metastatic hormone-sensitive prostate cancer. As a result, the overall...

    C. Thomas, C.‑H. Ohlmann in Der Urologe
    Article 09 April 2020
  13. Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors

    The role of truncated androgen receptor splice variant-7 (AR-V7) in prostate cancer biology is an unresolved question. Is it simply a marker of...

    Yezi Zhu, Susan L. Dalrymple, ... John T. Isaacs in Oncogene
    Article 28 September 2020
  14. Delineating the role of nuclear receptors in colorectal cancer, a focused review

    Colorectal cancer (CRC) stands as one of the most prevalent form of cancer globally, causing a significant number of deaths, surpassing 0.9 million...

    Mukesh Kumar Manickasamy, Sujitha Jayaprakash, ... Ajaikumar B. Kunnumakkara in Discover Oncology
    Article Open access 19 February 2024
  15. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors

    Purpose

    Androgen receptors (ARs) are expressed on a variety of cell types, and AR signaling plays an important role in tumor development and...

    Sahyun Pak, Wansuk Kim, ... Hanjong Ahn in Journal of Cancer Research and Clinical Oncology
    Article 10 August 2019
Did you find what you were looking for? Share feedback.